Camlin Fine Sciences 향후 성장

Future 기준 점검 4/6

Camlin Fine Sciences (는) 각각 연간 82.5% 및 19.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 82.2% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 13.9% 로 예상됩니다.

핵심 정보

82.5%

이익 성장률

82.19%

EPS 성장률

Chemicals 이익 성장	18.4%
매출 성장률	19.3%
향후 자기자본이익률	13.88%
애널리스트 커버리지	Low
마지막 업데이트	06 Jan 2026

최근 향후 성장 업데이트

Camlin Fine Sciences Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Nov 17

Recent updates

The Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Don't Inspire Confidence

Dec 09

It's Down 26% But Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Riskier Than It Looks

Dec 09

A Look At The Intrinsic Value Of Camlin Fine Sciences Limited (NSE:CAMLINFINE)

Sep 30

The Price Is Right For Camlin Fine Sciences Limited (NSE:CAMLINFINE) Even After Diving 31%

Aug 14

This Is Why Camlin Fine Sciences Limited's (NSE:CAMLINFINE) CEO Compensation Looks Appropriate

Aug 02

Revenues Tell The Story For Camlin Fine Sciences Limited (NSE:CAMLINFINE) As Its Stock Soars 49%

Jun 26

Is Camlin Fine Sciences (NSE:CAMLINFINE) A Risky Investment?

Jun 16

Investors Shouldn't Be Too Comfortable With Camlin Fine Sciences' (NSE:CAMLINFINE) Earnings

May 31

There's Reason For Concern Over Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Massive 25% Price Jump

May 10

The Market Lifts Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares 29% But It Can Do More

Feb 25

At ₹141, Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Worth Looking At Closely?

Feb 11

Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital

Jan 21

A Piece Of The Puzzle Missing From Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 26% Share Price Climb

Nov 27

Camlin Fine Sciences (NSE:CAMLINFINE) Will Be Hoping To Turn Its Returns On Capital Around

Oct 19

Camlin Fine Sciences (NSE:CAMLINFINE) Has A Somewhat Strained Balance Sheet

Mar 29

Positive Sentiment Still Eludes Camlin Fine Sciences Limited (NSE:CAMLINFINE) Following 26% Share Price Slump

Mar 29

Is There An Opportunity With Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 31% Undervaluation?

Sep 02

Is It Time To Consider Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE)?

Apr 06

Rainbows and Unicorns: Camlin Fine Sciences Limited (NSE:CAMLINFINE) Analysts Just Became A Lot More Optimistic

Feb 19

Camlin Fine Sciences Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Nov 17

Should You Think About Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE) Now?

Oct 15

Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares Could Be 32% Below Their Intrinsic Value Estimate

Jan 15

Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Paint A Concerning Picture

Jan 04

Why Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Worth Watching

Nov 30

Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital

Oct 05

At ₹163, Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Worth Looking At Closely?

Aug 20

이익 및 매출 성장 예측

NSEI:CAMLINFINE - 애널리스트 향후 추정치 및 과거 재무 데이터 (INR Millions)
날짜	매출	이익	자유현금흐름	영업현금흐름	평균 애널리스트 수
3/31/2028	28,191	1,579	1,584	2,236	1
3/31/2027	23,609	1,440	1,224	1,434	2
3/31/2026	19,185	172	1,007	863	2
9/30/2025	17,517	187	-168	283	N/A
6/30/2025	17,092	825	N/A	N/A	N/A
3/31/2025	16,665	685	-157	267	N/A
12/31/2024	16,540	-2,155	N/A	N/A	N/A
9/30/2024	16,064	-2,231	1,000	1,609	N/A
6/30/2024	15,893	-1,423	N/A	N/A	N/A
3/31/2024	14,539	651	784	1,390	N/A
12/31/2023	16,381	-8	N/A	N/A	N/A
9/30/2023	16,400	350	283	785	N/A
6/30/2023	17,174	674	N/A	N/A	N/A
3/31/2023	16,816	577	-934	509	N/A
12/31/2022	16,441	581	N/A	N/A	N/A
9/30/2022	16,371	628	-1,333	1,007	N/A
6/30/2022	14,650	442	N/A	N/A	N/A
3/31/2022	14,121	650	-683	1,454	N/A
12/31/2021	13,495	598	N/A	N/A	N/A
9/30/2021	12,666	465	-544	1,050	N/A
6/30/2021	12,122	579	N/A	N/A	N/A
3/31/2021	11,871	510	335	1,174	N/A
12/31/2020	11,533	394	N/A	N/A	N/A
9/30/2020	11,293	291	540	1,165	N/A
6/30/2020	10,948	302	N/A	N/A	N/A
3/31/2020	10,491	303	-481	860	N/A
12/31/2019	10,243	349	N/A	N/A	N/A
9/30/2019	9,918	277	-1,131	424	N/A
6/30/2019	9,709	221	N/A	N/A	N/A
3/31/2019	8,922	6	N/A	-90	N/A
12/31/2018	8,523	-139	N/A	N/A	N/A
9/30/2018	8,186	-222	N/A	N/A	N/A
6/30/2018	7,634	-277	N/A	N/A	N/A
3/31/2018	7,206	-338	N/A	-154	N/A
12/31/2017	6,403	-367	N/A	N/A	N/A
9/30/2017	5,676	-311	N/A	N/A	N/A
6/30/2017	5,347	-275	N/A	N/A	N/A
3/31/2017	5,339	-128	N/A	-87	N/A
12/31/2016	5,149	98	N/A	N/A	N/A
9/30/2016	5,013	174	N/A	N/A	N/A
6/30/2016	5,063	232	N/A	N/A	N/A
3/31/2016	4,893	358	N/A	716	N/A
12/31/2015	5,083	445	N/A	N/A	N/A
9/30/2015	5,238	463	N/A	N/A	N/A
6/30/2015	5,531	552	N/A	N/A	N/A
3/31/2015	5,583	550	N/A	463	N/A

애널리스트 향후 성장 전망

수입 대 저축률: CAMLINFINE 의 연간 예상 수익 증가율(82.5%)이 saving rate(6.8%)보다 높습니다.

수익 vs 시장: CAMLINFINE 의 연간 수익(82.5%)이 Indian 시장(16.6%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 수익: CAMLINFINE 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: CAMLINFINE 의 수익(연간 19.3%)이 Indian 시장(연간 10.8%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: CAMLINFINE 의 수익(연간 19.3%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: CAMLINFINE의 자본 수익률은 3년 후 13.9%로 낮을 것으로 예상됩니다.

성장 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터	최종 업데이트 (UTC 시간)
기업 분석	2026/01/22 10:43
종가	2026/01/22 00:00
수익	2025/09/30
연간 수익	2025/03/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
기업 재무제표	10년	손익계산서 현금흐름표 대차대조표	SEC 양식 10-K SEC 양식 10-Q
분석가 컨센서스 추정치	+3년	재무 예측 분석가 목표주가	분석가 리서치 보고서 Blue Matrix
시장 가격	30년	주가 배당, 분할 및 기타 조치	ICE 시장 데이터 SEC 양식 S-1
지분 구조	10년	주요 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
경영진	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발	10년	회사 공시	SEC 양식 8-K

^* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 Github 페이지에서 확인할 수 있으며, 보고서 활용 방법에 대한 가이드와 Youtube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Camlin Fine Sciences Limited는 9명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가	기관
Ankur Periwal	Axis Capital Limited
Abhishek Navalgund	Centrum Broking Limited
Satish Kumar	CGS International

Camlin Fine Sciences 향후 성장

Future 기준 점검 4/6

핵심 정보

최근 향후 성장 업데이트

Price target decreased by 25% to ₹200

Price target increased by 21% to ₹233

Camlin Fine Sciences Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Price target increased to ₹200

Recent updates

Now 22% overvalued

Now 28% overvalued

The Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Don't Inspire Confidence

It's Down 26% But Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Riskier Than It Looks

Camlin Fine Sciences Limited (BSE:532834) completed the acquisition of 78.68% stake in Vinpai SAS (ENXTPA:ALVIN) from Cyrille Damany, Philippe Le Ray, Chris Project, Alexandre de Selliers de Moranville, Saffelberg Investments NV, Jean-Marc Loiseau and others.

Now 24% overvalued

Second quarter 2026 earnings released: ₹0.29 loss per share (vs ₹5.98 loss in 2Q 2025)

Camlin Fine Sciences Limited to Report Q2, 2026 Results on Nov 10, 2025

Investor sentiment deteriorates as stock falls 15%

A Look At The Intrinsic Value Of Camlin Fine Sciences Limited (NSE:CAMLINFINE)

Now 22% overvalued

Now 20% overvalued

The Price Is Right For Camlin Fine Sciences Limited (NSE:CAMLINFINE) Even After Diving 31%

Camlin Fine Sciences Limited to Report Q1, 2026 Results on Aug 08, 2025

This Is Why Camlin Fine Sciences Limited's (NSE:CAMLINFINE) CEO Compensation Looks Appropriate

Now 21% undervalued

Full year 2025 earnings: EPS and revenues miss analyst expectations

New major risk - Revenue and earnings growth

Revenues Tell The Story For Camlin Fine Sciences Limited (NSE:CAMLINFINE) As Its Stock Soars 49%

Is Camlin Fine Sciences (NSE:CAMLINFINE) A Risky Investment?

Investors Shouldn't Be Too Comfortable With Camlin Fine Sciences' (NSE:CAMLINFINE) Earnings

Investor sentiment improves as stock rises 24%

Camlin Fine Sciences Limited, Annual General Meeting, Aug 08, 2025

Full year 2025 earnings: EPS and revenues miss analyst expectations

Camlin Fine Sciences Limited to Report Q4, 2025 Results on May 23, 2025

There's Reason For Concern Over Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Massive 25% Price Jump

New major risk - Revenue and earnings growth

Now 41% overvalued after recent price rise

Camlin Fine Sciences Limited Approves the Appointment of Pankaj Pawade as Senior General Manager, Effective on or Before May 20, 2025

New minor risk - Share price stability

Camlin Fine Sciences Limited (BSE:532834) agreed to acquire an unknown minority stake in Vinpai SAS (ENXTPA:ALVIN) from Cyrille Damany, Philippe Le Ray, Chris Project, Alexandre de Selliers de Moranville and others.

The Market Lifts Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares 29% But It Can Do More

Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 24% overvalued after recent price rise

Camlin Fine Sciences Limited Approves Appointment of Abeezar Faizullabhoy as Independent Director

At ₹141, Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Worth Looking At Closely?

Camlin Fine Sciences Limited to Report Q3, 2025 Results on Feb 14, 2025

Camlin Fine Sciences Limited Announces Cessation of Sutapa Banerjee as Independent Director

Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital

New minor risk - Share price stability

New major risk - Revenue and earnings growth

A Piece Of The Puzzle Missing From Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 26% Share Price Climb

Second quarter 2025 earnings released: ₹5.98 loss per share (vs ₹1.17 loss in 2Q 2024)

Camlin Fine Sciences Limited Appoints Saurabh Upadhyay as General Manager - Food Division Designated as Senior Management Personnel

Camlin Fine Sciences Limited to Report Q2, 2025 Results on Nov 11, 2024

Camlin Fine Sciences (NSE:CAMLINFINE) Will Be Hoping To Turn Its Returns On Capital Around

New major risk - Revenue and earnings growth

First quarter 2025 earnings released: ₹2.03 loss per share (vs ₹0.96 profit in 1Q 2024)

Camlin Fine Sciences Limited to Report Q1, 2025 Results on Aug 12, 2024

Full year 2024 earnings: EPS and revenues miss analyst expectations

New major risk - Revenue and earnings growth

Insufficient new directors

New minor risk - Insider selling

Camlin Fine Sciences Limited, Annual General Meeting, Jul 31, 2024

Full year 2024 earnings released: ₹5.58 loss per share (vs ₹3.45 profit in FY 2023)

Camlin Fine Sciences Limited to Report Q4, 2024 Results on May 20, 2024

Chairman & MD recently sold ₹225m worth of stock

Camlin Fine Sciences (NSE:CAMLINFINE) Has A Somewhat Strained Balance Sheet

Positive Sentiment Still Eludes Camlin Fine Sciences Limited (NSE:CAMLINFINE) Following 26% Share Price Slump

Third quarter 2024 earnings released: ₹0.71 loss per share (vs ₹1.53 profit in 3Q 2023)

Camlin Fine Sciences Limited to Report Q3, 2024 Results on Feb 09, 2024

Camlin Fine Sciences Limited Appoints Nilesh Jadhav as Chief Operating Officer

Second quarter 2024 earnings released: ₹1.17 loss per share (vs ₹0.83 profit in 2Q 2023)

Camlin Fine Sciences Limited to Report Q2, 2024 Results on Nov 06, 2023

Price target decreased by 25% to ₹200

Is There An Opportunity With Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 31% Undervaluation?

First quarter 2024 earnings released: EPS: ₹0.96 (vs ₹0.37 in 1Q 2023)

Camlin Fine Sciences Limited to Report Q1, 2024 Results on Aug 11, 2023

Full year 2023 earnings: EPS misses analyst expectations

Camlin Fine Sciences Limited, Annual General Meeting, Jul 31, 2023

Full year 2023 earnings: EPS misses analyst expectations